China CDC http://www.chinacdc.cn/en/

China CDC http://www.chinacdc.cn/en/

National Health Commission of the People’s Republic of China [to 18 Dec 2021]
http://en.nhc.gov.cn/
News
Dec 18: Daily briefing on novel coronavirus cases in China
On Dec 17, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 125 new cases of confirmed infections.

COVID-19 fight enters ‘critical period’
2021-12-17
The fight against the COVID-19 outbreak in East China’s Zhejiang province has entered “the most critical period”, a top provincial health official said on Dec 16.

National Medical Products Administration – PRC [to 18 Dec 2021]
http://english.nmpa.gov.cn/
News
Over 2.64b COVID-19 vaccine doses administered on Chinese mainland
2021-12-16
More than 2.64 billion COVID-19 vaccine doses had been administered on the Chinese mainland as of Wednesday, data from the National Health Commission showed on Dec 16.

Over 1.16b Chinese fully vaccinated against COVID-19
2021-12-13
Over 1.16 billion Chinese people have been fully vaccinated against COVID-19, a spokesperson for the National Health Commission said at a press conference on Dec 11.

CCDC Weekly – Weekly Reports: Current Volume (3)
2021-12-17 / No. 51 PARASITIC DISEASES ISSUE (3)
View  PDF of this issue
Preplanned Studies: Epidemiological and Clinical Features of Patients with Scrub Typhus — Guangzhou City, Guangdong Province, China, 2012–2018
Preplanned Studies: Epidemiological Characteristics of Echinococcosis in Non-Endemic PLADs — China, 2017–2020
Preplanned Studies: Rapid Assessment on Potential Risks of Schistosomiasis Transmission — 7 PLADs, China, 2019 and 2021
Preplanned Studies: Reappearance of Risk of Schistosomiasis Transmission and the Response After 27 Years of Interrupted Transmission — Guangdong Province, China, 2019
Notifiable Infectious Diseases Reports: Reported Cases and Deaths of National Notifiable Infectious Diseases — China, October, 2021

Organization Announcements

::::::

 
 
Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.
 
 
Paul G. Allen Frontiers Group [to 18 Dec 2021]
https://alleninstitute.org/news-press/
News
Hundreds of small molecules known as neuromodulators might influence how we learn
December 17, 2021
New models that capture how the brain retains information could also improve machine learning

Press Release
Allen Institute announces Rui Costa as next President and Chief Executive Officer
December 16, 2021
The Allen Institute today named Rui Costa, D.V.M., Ph.D., as its next president and chief executive officer. Costa comes to the Allen Institute from the Mortimer B. Zuckerman Mind Brain Behavior Institute at Columbia University in New York where he has served as CEO since 2017, and currently serves on the Allen Institute’s Brain Science Scientific Advisory Council…
 
 
BARDA – U.S. Department of HHS [to 18 Dec 2021]
https://www.phe.gov/about/barda/Pages/default.aspx
News
No new digest content identified.
 
 
BMGF – Gates Foundation [to 18 Dec 2021]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
No new digest content identified.
 
 
Bill & Melinda Gates Medical Research Institute [to 18 Dec 2021]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X [to 18 Dec 2021]
https://carb-x.org/
News
No new digest content identified.
 
 
Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 18 Dec 2021]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: Informed Consent: A Monthly Review – December 2021 is now posted here
 
 
CEPI – Coalition for Epidemic Preparedness Innovations [to 18 Dec 2021]
http://cepi.net/
Latest News
CEPI statement: CEO welcomes Emergency Use Listing for NVX-CoV2373
CEPI-supported vaccine is the first protein-based vaccine to receive EUL, a prerequisite for distribution through COVAX.
17 Dec 2021

CEPI partners with Affinivax to develop a novel COVID-19 vaccine to target variants
New partnership will advance the development of a novel vaccine that could provide broad protection against SARS-CoV-2 variants, and potentially other betacoronaviruses… EPI will provide funding of up to $4.5 million to support the initial development of a vaccine candidate based on Affinivax’s innovative Multiple Antigen Presenting System (MAPSTM) technology platform.
13 Dec 2021
 
 
DARPA – Defense Advanced Research Projects Agency [to 18 Dec 2021
https://www.darpa.mil/news
News
No new digest content identified.
 
 
Duke Global Health Innovation Center [to 18 Dec 2021]
https://dukeghic.org/
Our Blog
No new digest content identified.
 
 
EDCTP [to 18 Dec 2021]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
News
No new digest content identified.
 
 
Emory Vaccine Center [to 18 Dec 2021]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.
 
 
European Vaccine Initiative [to 18 Dec 2021]
http://www.euvaccine.eu/
Latest News, Events
No new digest content identified.
 
 
Fondation Merieux [to 18 Dec 2021]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.
 
 
Gavi [to 18 Dec 2021]
https://www.gavi.org/
News Releases
No new digest content identified.

GHIT Fund [to 18 Dec 2021]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.
 
 
Global Fund [to 18 Dec 2021]
https://www.theglobalfund.org/en/news/
News & Stories
News
Ethics Resources for Country Coordinating Mechanisms: New e-learning Module
17 December 2021
A new e-learning module has been launched to help Country Coordinating Mechanisms (CCM) maintain high standards of ethics and integrity in their work and decision making. The new module focuses on Duty of Care (including Oversight) and Accountability (including Transparency) and is available on iLearn in English. It will soon be available in French and Spanish. This fifth module concludes the CCM Code of Conduct training series.
The e-learning module can be found on the Country Coordinating Mechanism Ethics section, along with the other code of conduct modules for CCM members and related information.
 
 
Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 18 Dec 2021]
https://www.glopid-r.org/news/
News
No new digest content identified.
 
 
Hilleman Laboratories [to 18 Dec 2021]
http://www.hillemanlabs.org/
News & Insights
No new digest content identified.
 
 
HHMI – Howard Hughes Medical Institute [to 18 Dec 2021]
https://www.hhmi.org/news
Press Room
Research Dec 15 2021
Flies Navigate Using Complex Mental Math
For the first time, scientists have shown exactly how a fly brain creates a mental map of the body’s movement through the world.
 
 
Human Vaccines Project [to 18 Dec 2021]
http://www.humanvaccinesproject.org/
News
No new digest content identified.
 
 
IAVI [to 18 Dec 2021]
https://www.iavi.org/newsroom
Latest News
No new digest content identified.

 
 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.
 
 
ICRC [to 18 Dec 2021]
https://www.icrc.org/en/whats-new
Selected News Releases, Statements, Reports
ICRC collaborates with artists in urgent call for equitable access to COVID-19 vaccine
The ICRC has collaborated with artists from Asia-Pacific on illustrations to emphasize the importance and call for the equitable access to COVID-19 vaccines.
16-12-2021 | Article

 
 

IFFIm
http://www.iffim.org/
Press Releases/Announcements
Lessons on COVID-19 from Africa: Q&A with Hassatou N’Sele
17 Dec 2021
Hassatou N’Sele joined IFFIm’s Board of Directors on 1 July 2021. As the Treasurer of the African Development Bank Group (AfDB) based in Abidjan, Cote d’Ivoire, she leads the expansion of the AfDB capital markets activities across the globe. Ms N’Sele is a Senegalese citizen. Tell us about your life. What experiences and people shaped you as a per…

The Wild Side of Innovative Finance: Q&A with Monique Barbut
17 Dec 2021
Monique Barbut joined IFFIm’s Board of Directors in July 2021. Currently the President of the World Wildlife Fund France, Ms Barbut has spent her extensive career in public service, playing a key role in environmental and financial global negotiations at the U.N.

Channeling private sector participation to optimise results: Q&A with Ingrid van Wees
17 Dec 2021
Ingrid van Wees joined the IFFIm board on 1 October 2021. She is currently the Vice President for Finance and Risk Management of the Asian Development Bank (ADB), based in Manila, the Philippines.
 
 
IFRC [to 18 Dec 2021]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
16/12/2021
DRC: Media statement on the end of the 13th Ebola outbreak
Beni/Kinshasa/Nairobi/Geneva, 16 December 2021—The Red Cross of the Democratic Republic of Congo (DRC) joins the International Federation of Red Cross and Red Crescent Societies (IFRC) in celebrating the end of the 13th Ebola outbreak in the country.
The Minister of Public Health, Hygiene and Prevention of the DRC, officially declared, this 16 December 2021, the end of the 13th outbreak of Ebola Virus Disease which resurfaced on 8 October 2021, in the health zone of Beni in the province of North Kivu.
This declaration comes 42 days after the last patient tested negative.
A cumulative 11 cases were recorded during this 13th outbreak, including 8 deaths and 2 cured…

16/12/2021
Red Cross Red Crescent reaching 1.5 million people on the move in MENA, yet millions are left without support
 
 
Institut Pasteur [to 18 Dec 2021]
https://www.pasteur.fr/en/press-area
Press Documents
Press release 06.12.2021
Chronic obstructive pulmonary disease: a genetic mutation confirmed as predisposing factor
In 2019, the WHO positioned chronic obstructive pulmonary disease (COPD) third in the global ranking of causes of death…
 
 
IOM / International Organization for Migration [to 18 Dec 2021]
http://www.iom.int/press-room/press-releases
News – Selected
News
15 Dec 2021
IOM Launches COVID-19 Vaccination Campaign for Migrants in Yemen
Aden – The International Organization for Migration (IOM) has begun a COVID-19 vaccination campaign for migrants stranded in Yemen, aiming to inoculate around 7,500 people at its Migrant Response Points in Aden and Ma’rib. IOM continues to advocate for more efforts to protect vulnerable populations by ramping up vaccination efforts for people on the move.
“We welcome the Government’s commitment to protecting migrants against COVID-19 and immunizing people on the move is key to combatting the spread of the disease,” said IOM’s Chief of Mission, Christa Rottensteiner. “There are still not enough doses to protect everyone in Yemen from this disease. More support from the international community to supply the country with enough vaccines will save lives.”…
So far this year, more than 135,000 people have been reached with COVID-19 awareness sessions and over 400,000 people have been screened for COVID-19 at IOM-supported health facilities throughout the country.
IOM’s vaccination campaign for migrants in Yemen is implemented in partnership with the Ministry of Health and the World Health Organization with support by contributions from the governments of Germany, Finland and EU Humanitarian Aid.
 
 
ISC / International Science Council [to 18 Dec 2021]
https://council.science/current/
ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.
News
No new digest content identified.
 
 
IVAC [to 18 Dec 2021]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
No new digest content identified.
 
 
IVI [to 18 Dec 2021]
http://www.ivi.int/
IVI News & Announcements
IVI to establish a European regional office in Sweden
IVI and the Government Offices of Sweden signed a Memorandum of Understanding today to establish the office in Stockholm, creating a European hub for global health research and innovation
December 17, 2021
 
 
Johns Hopkins Center for Health Security [to 18 Dec 2021]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
New Report: Integrating Primary Care and Public Health to Save Lives and Improve Practice During Public Health Crises: Lessons from COVID-19
December 14, 2021
Today, the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health released a new report finding that the failure to bring primary care providers into a frontline role as responders to the COVID-19 pandemic, alongside the public health system, resulted in many missed opportunities to provide better quality care, faster testing, more effective contact tracing, greater acceptance of vaccination, and better communication with patients.
The new report, Integrating Primary Care and Public Health to Save Lives and Improve Practice During Public Health Crises: Lessons from COVID-19, also identified other unrealized benefits that could have helped, had there been better integration of primary care, public health, and community-based organizations: 1) Greater support for the public health response, thereby easing the burden on overstretched public health personnel; and 2) ability to access primary care’s reach to amplify public health messaging…
 
 
MSF/Médecins Sans Frontières [to 18 Dec 2021]
http://www.msf.org/
Latest [Selected Announcements]
Brazil
Venezuelan migrants left without healthcare, shelter and services
Project Update 14 Dec 2021
 
 
National Academy of Medicine – USA [to 18 Dec 2021]
https://nam.edu/programs/
Selected News/Programs/Events
No new digest content identified.
 
 
National Academy of Sciences – USA [to 18 Dec 2021]
http://www.nasonline.org/news-and-multimedia/
News
No new digest content identified.
 
 
National Vaccine Program Office – U.S. HHS [to 18 Dec 2021]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
No new digest content identified.
 
 
NIH [to 18 Dec 2021]
http://www.nih.gov/news-events/news-releases
News Releases
NIH scientists urge pursuit of universal coronavirus vaccine
December 16, 2021 — A growing body of scientific evidence suggests that novel coronaviruses will continue to have potential to emerge as a threat to humans.
DM Morens, et al. Universal coronavirus vaccines—an urgent need. The New England Journal of Medicine. DOI: 10.1056/NEJMp2118468(link is external) (2021).
[See Milestones/Perspectives above for detail]
 
 
OECD [to 18 Dec 2021]
http://www.oecd.org/newsroom/publicationsdocuments/bydate/
Newsroom
No new digest content identified.
 
 
PATH [to 18 Dec 2021]
https://www.path.org/media-center/
Press Releases
No new digest content identified.
 
 
Sabin Vaccine Institute [to 18 Dec 2021]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.
 
 
UNAIDS [to 18 Dec 2021]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
13 December 2021
Key population participation in HIV decision-making varies

UNHCR Office of the United Nations High Commissioner for Refugees [to 18 Dec 2021]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
No new digest content identified.

UNICEF [to 18 Dec 2021]
https://www.unicef.org/media/press-releases
Press Releases, News Notes, Statements [Selected]
Statement
12/17/2021
Even as Omicron variant takes hold, school closures must be a measure of last resort
Statement by UNICEF Executive Director Henrietta Fore
 
 
Unitaid [to 18 Dec 2021]
https://unitaid.org/
Featured News
17 December 2021
Unitaid launches call for proposals to prevent hepatitis C in the most marginalised and at-risk groups
Geneva – An estimated 58 million people worldwide are infected with hepatitis C, a blood-borne virus that can lead to serious liver disease. This virus, which causes an estimated 300,000 deaths each year, affects people who inject drugs and incarcerated populations at much higher rates.
Unitaid is therefore seeking to fund innovative projects that will expand access to new tools or under-utilised interventions to prevent and treat hepatitis C, with a particular focus on these key groups in low- and middle-income countries…

16 December 2021
Former French Minister Marisol Touraine reelected chair of the Unitaid Executive Board; Unitaid on track to deliver its new strategy for 2022-26
 
 
USAID [to 18 Dec 2021]
https://www.usaid.gov/news-information/press-releases/2021
Selected Press Releases, Statements, Announcements
Administrator Samantha Power Holds Meetings on COVID-19 Vaccine Access and Delivery Efforts
December 17, 2021
This week, USAID Administrator Samantha Power held a series of high-level meetings with key United States and world health experts to discuss the recently announced whole-of-government effort, the Initiative for Global Vaccine Access (Global VAX). Vaccinating the world is the best way to save lives, prevent future variants that threaten the health of communities around the world, including Americans, and undermine the global economic recovery. As more vaccine supply flows to low and middle income countries, the United States is redoubling efforts to help countries efficiently and effectively receive, distribute, and administer doses. Global VAX focuses on accelerating global efforts to get shots in arms —particularly in sub-Saharan Africa—and to enhance international coordination to rapidly overcome barriers to vaccine delivery.
 
 
Vaccine Equity Cooperative [nee Initiative] [to 18 Dec 2021]
https://vaccineequitycooperative.org/news/
News
No new digest content identified.
 
 
Vaccination Acceptance & Demand Initiative [Sabin) [to 18 Dec 2021]
https://www.vaccineacceptance.org/
Announcements
Focusing on Marginalized Communities
Get to Know Two of Our 2021 Social and Behavioral Research Grant Partners
December 14, 2021
By: Abigail Quinn, BA, Deeva Agravat, MSc, Kate Hopkins, PhD, MPH
 
 
Vaccine Confidence Project [to 18 Dec 2021]
http://www.vaccineconfidence.org/
News, Research and Reports
No new digest content identified.
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia [to 18 Dec 2021]
http://www.chop.edu/centers-programs/vaccine-education-center
News
No new digest content identified.
 
 
Wellcome Trust [to 18 Dec 2021]
https://wellcome.ac.uk/news
News. Opinion, Reports
News
How to prevent another major pandemic
15 December 2021
The world could have been much better prepared for Covid-19. So now we must ask: How well prepared are we going to be for the next pandemic?
 
 
The Wistar Institute [to 18 Dec 2021]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.
 
 
WFPHA: World Federation of Public Health Associations [to 18 Dec 2021]
https://www.wfpha.org/
Latest News – Blog
Facing Leadership that Kills!
Dec 15, 2021 | News
Facing Leadership that Kills! An Article by Public Health Leadership Coalition’s Member – Dr. Alejandro R. Jadad Despite the growing number of reports describing myriad ways in which leaders failed the populations they were meant to protect during the COVID-19…
 
 
World Bank [to 18 Dec 2021]
http://www.worldbank.org/en/news/all
Selected News, Announcements
Ukraine to Expand COVID-19 Vaccination, with Additional World Bank Financing
WASHINGTON, December 10, 2021 – The World Bank’s Board of Executive Directors approved today $150 million in Additional Financing for the Ukraine Emergency COVID-19 Response and Vaccination Project…
Date: December 10, 2021 Type: Press Release

Learning Losses from COVID-19 Could Cost this Generation of Students Close to $17 Trillion in Lifetime Earnings
World Bank-UNESCO-UNICEF report lays out the magnitude of the education crisis WASHINGTON, DC, Dec. 6, 2021—This generation of students now risks losing $17 trillion in lifetime earnings in present…
Date: December 06, 2021 Type: Press Release

The State of the Global Education Crisis: A Path to Recovery
The global disruption to education caused by the COVD-19 pandemic is without parallel and the effects on learning are severe. The crisis brought education systems across the world to a halt, with school…
Date: December 03, 2021 Type: Publication
 
 
World Organisation for Animal Health (OIE) [to 18 Dec 2021]
https://www.oie.int/en/media/news/
Press Releases, Statements
No new digest content identified.
 
 
WTO – World Trade Organisation [to 18 Dec 2021]
http://www.wto.org/english/news_e/news_e.htm
WTO News and Events
Members continue discussions on IP COVID-19 response as high-level engagement intensifies
16 December 2021
WTO members agreed to continue their discussions on a common intellectual property (IP) response to COVID-19 amid the ongoing high-level political dialogue aimed at finding a consensus-based outcome. At a formal meeting of the Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) on 16 December, members reported on the bilateral meetings and small group consultations held following the postponement of the 12th WTO Ministerial Conference and reiterated their willingness and intention to intensify their engagement with each other.
[See Milestones/Perspectives above for detail]

WTO updates note on trade in medical goods in the context of COVID-19
16 December 2021
The WTO Secretariat has published an update of the information note on trade in medical goods in the context of tackling COVID-19, which was first issued in April 2020, a few months after the World Health Organization declared COVID-19 a public health emergency of international concern. The update looks at developments in the first half of 2021.
The updated note indicates that in the first half of 2021, trade in medical goods maintained solid growth, comprising 6.1 per cent of total world trade compared to 5.4 per cent for the second half of 2019, just before the pandemic outbreak.
Trade in medical goods grew by 12.4 per cent in the first half of 2021 compared with the same period in 2020. This increase was slower than the year-on-year growth for the second half of 2020, at 17.1 per cent, but it is an increase of 31 per cent compared to the first half of 2019. It is also a continuation of the strong growth (16 per cent) recorded in 2020.
The update features a case study on the critical products needed for administering COVID-19 vaccines. This highlights that as vaccination numbers increased, the highest year-on-year growth (34.8 per cent) was for medical supplies, including items critical for administering vaccines (rubber gloves, syringes and needles).
Trade in testing materials and diagnostic reagents also remained high, growing by 54.5 per cent in the first half of 2021 compared to the same period of 2020.
The first information note on “Trade in medical goods in the context of tackling COVID-19” was issued on 3 April 2020, with previous updates issued on 20 December 2020 and 30 June 2021. The updated note can be found here.

 

::::::
 
 
ARM [Alliance for Regenerative Medicine] [to 18 Dec 2021]
https://alliancerm.org/press-releases/
Selected Press Releases
No new digest content identified.
 
 
BIO [to 18 Dec 2021]
https://www.bio.org/press-releases
Press Releases, Letters, Testimony, Comments [Selected]
No new digest content identified.
 
 
DCVMN – Developing Country Vaccine Manufacturers Network [to 18 Dec 2021]
http://www.dcvmn.org/
News; Upcoming events
16 December 2021
Press release: 11 billion COVID-19 vaccines produced in 2021 has resulted in the biggest immunization campaign in human history and 2022 will require more and better vaccine redistribution and innovation
[See Milestones/Perspectives above for detail]
 
 
ICBA – International Council of Biotechnology Associations [to 18 Dec 2021]
https://internationalbiotech.org/news/
News
No new digest content identified.
 
 
IFPMA [to 18 Dec 2021]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
11 billion COVID-19 vaccines produced in 2021 has resulted in the biggest immunization campaign in human history and 2022 will require more and better vaccine redistribution and innovation
Published on: 16 December 2021
[See Milestones/Perspectives above for detail]

Position paper – Synthetic follow-on products that reference biologically produced medicines
15 December 2021
What is the challenge?
In some countries, there is lack of clarity about how these products should be regulated….“Synthetic follow-on products that reference a biologically produced medicine are complex and should not be viewed as simple generics. Instead, they should be evaluated following an approach more aligned with that adopted for biosimilars.”

Technology Transfer: A Collaborative Approach to Improve Global Health
13 December 2021

 
 
 
International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.
 
 
International Alliance of Patients’ Organizations – IAPO [to 18 Dec 2021]
https://www.iapo.org.uk/news/topic/6
Press and media [Selected]
Joint Statement On Patient Solidarity Day 2021
London, December 3rd, 2021 – On Patient Solidarity Day, the International Alliance of Patients’ Organizations (IAPO), the International Pharmaceutical Federation (FIP), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA),  International Hospital Federation (IHF) and the International Council of Nurses (ICN) , join patients and families all over the world, in calling for governments and all health stakeholders to collaborate in the implementation of the WHO Flagship Global Patient Safety Action Plan 2021-2030 (GPSAP 2021-30) that was adopted at the 74th World Health Assembly this year.
 
 
PhRMA [to 18 Dec 2021]
http://www.phrma.org/
Latest News [Selected]
No new digest content identified.

Journal Watch

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Capacity of community advisory boards for effective engagement in clinical research: a mixed methods study

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 18 Dec 2021)

 

Capacity of community advisory boards for effective engagement in clinical research: a mixed methods study
Authors: Levicatus Mugenyi, Andrew Mijumbi, Mastula Nanfuka, Collins Agaba, Fedress Kaliba, Irene Seryazi Semakula, Winfred Badanga Nazziwa and Joseph Ochieng
Content type: Research
15 December 2021

Reproducibility and research integrity: the role of scientists and institutions

BMC Research Notes
http://www.biomedcentral.com/bmcresnotes/content
(Accessed 18 Dec 2021)

 

Commentary
Reproducibility and research integrity: the role of scientists and institutions
Authors: Patrick Diaba-Nuhoho and Michael Amponsah-Offeh
Citation: BMC Research Notes 2021 14:451
Published on: 14 December 2021
Abstract
Reproducibility and research integrity are essential tenets of every scientific study and discovery. They serve as proof that an established and documented work can be verified, repeated, and reproduced. New knowledge in the biomedical science is built on the shoulders of established and proven principles. Thus, scientists must be able to trust and build on the knowledge of their colleagues. Scientific innovation and research discoveries especially in the field of medicine has contributed to improving the lives of patients and increasing life expectancies. However, the growing concerns of failure to comply with good scientific principles has resulted in issues with research integrity and reproducibility. Poor reproducibility and integrity, therefore, may lead to ineffective interventions and applications. Here we comment on research reproducibility in basic medical and life sciences with regards to issues arising and outline the role of stakeholders such as research institutions and their employees in addressing this crisis.

Localisation and local humanitarian action

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/localisation-and-local-humanitarian-action/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

From mRNA sensing to vaccines

Immunity
Dec 14, 2021 Volume 54 Issue 12 p2671-2922
https://www.cell.com/immunity/current

 

Featured Article
From mRNA sensing to vaccines
Anthony S. Fauci, et al.
The 2005 Immunity paper by Karikó et al. has been hailed as a cornerstone insight that directly led to the design and delivery of the mRNA vaccines against COVID-19. We asked experts in pathogen sensing, vaccine development, and public health to provide their perspective on the study and its implications.

Antigenic drift: Understanding COVID-19

Immunity
Dec 14, 2021 Volume 54 Issue 12 p2671-2922
https://www.cell.com/immunity/current

 

Primer
Antigenic drift: Understanding COVID-19
Jonathan W. Yewdell
Antigenic drift refers to the evolutionary accumulation of amino acid substitutions in viral proteins selected by host adaptive immune systems as the virus circulates in a population. Antigenic drift can substantially limit the duration of immunity conferred by infection and vaccination. Here, I explain the factors contributing to the rapid antigenic drift of the SARS-CoV-2 spike protein and receptor proteins of other viruses and discuss the implications for SARS-CoV-2 evolution and immunity.

mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants

Immunity
Dec 14, 2021 Volume 54 Issue 12 p2671-2922
https://www.cell.com/immunity/current

 

Articles
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants
Aurélien Sokal, et al.
To better understand B cell responses to SARS-CoV-2 mRNA vaccination, Sokal et al. analyzed memory B cells from COVID-19-recovered and naive individuals. In recovered individuals, vaccination amplifies a broad repertoire of matured MBCs and generates variant-neutralizing plasma cells. In naive individuals, vaccination induces an MBC pool containing potent neutralizing clones against all current variants of concern, including beta and delta.

Pediatric COVID-19 Vaccines What Parents, Practitioners, and Policy Makers Need to Know

JAMA
December 14, 2021, Vol 326, No. 22, Pages 2239-2339
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Pediatric COVID-19 Vaccines What Parents, Practitioners, and Policy Makers Need to Know
William J. Moss, MD, MPH; Lawrence O. Gostin, JD; Jennifer B. Nuzzo, DrPH, SM
JAMA. 2021;326(22):2257-2258. doi:10.1001/jama.2021.20734
This Viewpoint discusses the Food and Drug Administration granting Emergency Use Authorization of the mRNA COVID-19 vaccine BNT162b2 for children aged 5 to 11 years and the role that will play in keeping children, schools, and communities safe.

Incentivizing a New Culture of Data StewardshipThe NIH Policy for Data Management and Sharing

JAMA
December 14, 2021, Vol 326, No. 22, Pages 2239-2339
https://jamanetwork.com/journals/jama/currentissue

 

Incentivizing a New Culture of Data StewardshipThe NIH Policy for Data Management and Sharing
Lyric A. Jorgenson, PhD; Carrie D. Wolinetz, PhD; Francis S. Collins, MD, PhD
JAMA. 2021;326(22):2259-2260. doi:10.1001/jama.2021.20489
This Viewpoint cites the data collaboration during the COVID-19 pandemic as an example of unprecedented vaccine results and points to the NIH’s Policy for Data Management and Sharing to foster shared data as a routine part of grant applications.

Call for emergency action to limit global temperature increases, restore biodiversity and protect health (5 September, 2021)

Journal of Epidemiology & Community Health
December 2021 – Volume 75 – 12
https://jech.bmj.com/content/75/12

 

Editorial
Call for emergency action to limit global temperature increases, restore biodiversity and protect health (5 September, 2021)
Lukoye Atwoli, Abdullah H Baqui, Thomas Benfield, Raffaella Bosurgi, Fiona Godlee, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Carlos Augusto Monteiro, Ian Norman, Kirsten Patrick, Nigel Praities, Marcel GM Olde Rikkert, Eric J Rubin, Peush Sahni, Richard Smith, Nicholas J Talley, Sue Turale, Damián Vázquez

COVID-19: where do we go from here?

The Lancet
Dec 18, 2021 Volume 398 Number 10318 p2207-2306
https://www.thelancet.com/journals/lancet/issue/current

 

Editorial
COVID-19: where do we go from here?
The Lancet
The end of 2021 brings a sense of uncertainty. Parts of the world are approaching a transition or a new phase of the COVID-19 pandemic. The window for pursuing the elimination of SARS-CoV-2 has closed. Moving towards a so-called post-pandemic world will be far more complicated than scenarios such as “Zero COVID”. The challenge now is to determine the level of COVID-19 that is acceptable for individual nations in a fundamentally interconnected world. In the first Lancet Editorial of 2021, we noted: “Countries might justifiably start to look inward to repair the damage after COVID-19. But equitable access, whether to a vaccine, food, or finance, will require global collaboration.” This requirement has not been met. Science has provided the tools and evidence to control the COVID-19 pandemic, but the response has been shaped by political factors and a lack of cooperation, often to the detriment of health.

For all its peaks and troughs, 2021 should be heralded as the year of extraordinary COVID-19 science. 2021 began with several new vaccines showing efficacy in randomised trials. There are now 26 COVID-19 vaccines authorised by at least one national regulatory agency and another 200 candidates are in development. Novel treatments have provided further options to prevent death and disability. These achievements allowed for a new sense of hope that should have been the basis for an equitable global response, carried out with the urgency and seriousness that a devastating pandemic demands.

Massive vaccine roll-out programmes have also taken place with remarkably high participation in some countries, including Portugal (88%), Chile (86%), Cuba (83%), and Singapore (83%). Yet vaccination rates are notably lower in other countries that had early access to a COVID-19 vaccine—eg, Russia has reached only about 48% of its population as of December, 2021. Of all Americans who are eligible, only 61% are fully vaccinated. Although in vastly different contexts, those who are unvaccinated in Russia and the USA cite the same reasons: a mistrust of government, distrust of data, and few consequences for not being vaccinated.

The USA provides a potent demonstration of the structural barriers and stymied progress in COVID-19 that can originate from political obstacles to health. Socioeconomic disadvantage is a substantial contributor to vaccine hesitancy in low-income communities. Compliance with public health interventions, such as indoor masking, are often fomented by political ideologies. Lawsuits filed in federal appeal courts by Republican political action groups have thwarted vaccine mandate legislation for health-care workers and federal employees that would go into effect in 2022. A sizeable proportion of unvaccinated-by-choice Americans remain so even though they are eligible to receive a booster. Without incentives to reduce hesitancy, durable mandates for masking, and near complete vaccination, optimism dims for curtailing the next potential COVID-19 wave.

Political failures to cooperate and find solutions at the global level have shaped the pandemic too. Leaders of high-income countries have spoken of the importance of equitable access to COVID-19 vaccination, and pledged to donate doses, but have consistently been unable to deliver. Vaccine manufacturing continues to be hindered by a lack of agreement on relaxing intellectual property rules to increase and diversify capacity. The enormity of the situation has not been matched by the response. Leaders have been unable to realise that the status quo should not apply in a pandemic. As of this month, 75% of the population in high-income countries have received at least one dose of a COVID-19 vaccine compared with 46% in lower-middle-income countries, and just 7% in low-income countries. The emergence of new variants such as omicron jeopardises all.

Politically driven decisions are undermining health security. The most recent Global Health Security Index shows that risks to political stability and security have increased in nearly all countries, and those with the fewest resources have the highest risk. There is greater risk of social unrest. Most countries score low on accountability of public officials and human rights. All countries remain underprepared for the next pandemic and countries should be more transparent about their capacities and risk factors for better global preparation.

The emergence of omicron threatens new setbacks and further compounding of the harms of the pandemic. Science will no doubt continue to provide the means to respond. But doing so effectively and equitably will require greater recognition of the political determinants of health and action based on a robust global multilateral system and strong individual national leadership—which too often has been, and continues to be, lacking.

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

The Lancet
Dec 18, 2021 Volume 398 Number 10318 p2207-2306
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Alasdair P S Munro, et al. on behalf of the COV-BOOST study group
Open Access
Interpretation
All study vaccines boosted antibody and neutralising responses after ChAd/ChAd initial course and all except one after BNT/BNT, with no safety concerns. Substantial differences in humoral and cellular responses, and vaccine availability will influence policy choices for booster vaccination.

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

The Lancet
Dec 18, 2021 Volume 398 Number 10318 p2207-2306
https://www.thelancet.com/journals/lancet/issue/current

 

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
Rajeka Lazarus, et al. and the ComfluCOV Trial Group
Open Access
Interpretation
Concomitant vaccination with ChAdOx1 or BNT162b2 plus an age-appropriate influenza vaccine raises no safety concerns and preserves antibody responses to both vaccines. Concomitant vaccination with both COVID-19 and influenza vaccines over the next immunisation season should reduce the burden on health-care services for vaccine delivery, allowing for timely vaccine administration and protection from COVID-19 and influenza for those in need.

The emergence, genomic diversity and global spread of SARS-CoV-2

Nature
Volume 600 Issue 7889, 16 December 2021
https://www.nature.com/nature/volumes/600/issues/7889

 

Review Article | 08 December 2021
The emergence, genomic diversity and global spread of SARS-CoV-2
The potential origins and global spread of SARS-CoV-2, the emergence of SARS-CoV-2 variants of concern and the importance of genomic surveillance for the control of the COVID-19 pandemic are discussed.
Juan Li, Shengjie Lai, Weifeng Shi

Mapping the human genetic architecture of COVID-19

Nature
Volume 600 Issue 7889, 16 December 2021
https://www.nature.com/nature/volumes/600/issues/7889

 

Article | 08 July 2021 | Open Access
Mapping the human genetic architecture of COVID-19
A global network of researchers was formed to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity; this paper reports 13 genome-wide significant loci and potentially actionable mechanisms in response to infection.
Mari E. K. Niemi, Juha Karjalainen, Chloe Donohue

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

Nature
Volume 600 Issue 7889, 16 December 2021
https://www.nature.com/nature/volumes/600/issues/7889

 

Article | 07 October 2021 | Open Access
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Individual memory antibodies selected over time by natural infection with SARS-CoV-2 have greater potency and breadth than antibodies elicited by vaccination, whereas the overall neutralizing potency of plasma is greater following vaccination.
Alice Cho, Frauke Muecksch, Michel C. Nussenzweig

Technologies to advance COVID-19 vaccine equity

Nature Biotechnology
Volume 39 Issue 12, December 2021
https://www.nature.com/nbt/volumes/39/issues/12

 

Editorial | 06 December 2021
Technologies to advance COVID-19 vaccine equity
Poor countries need vaccine formats with low barriers to manufacture, distribution and administration.
…The massive global effort over the past two years to develop, make, and administer vaccines against a novel, fast-spreading pathogen is unprecedented in the history of vaccines. The results are still unfolding and will have much to teach us about both the immunology of viral infection and the strengths and weaknesses of emerging COVID-19 vaccine technologies. With international cooperation and open data sharing, they may shed light on some of the most intractable problems in vaccinology: how best to make mucosal vaccines, how to induce robust immunity in the immunocompromised or aged people with immunosenescence, how best to increase the longevity of protection, and how to elicit broadly neutralizing antibodies against diverse viral lineages or a rapidly mutating virus.

The knowledge gained could lead to more-effective COVID-19 vaccines. Current vaccines greatly diminish the risks of infection, transmission, serious illness, and death but do not entirely prevent them, with immunocompromised and elderly people the most vulnerable. Efficacy wanes in a matter of months (in the age cohorts for which data are available — 16 and up). Improvements that can be envisaged include intranasal or oral vaccines for stronger mucosal immunity to reduce infection and transmission, and pan-sarbecovirus vaccines to protect against all SARS coronavirus strains.

No single vaccine will be best for every country and every pandemic condition. But we need to ensure that all people, including those in poor, rural, or remote communities, have access to highly effective and safe COVID-19 vaccines. Vaccine technologies that are validated for COVID-19 may also aid the development of vaccines for other infectious diseases, such as tuberculosis, pandemic influenza, malaria, and respiratory syncytial virus infection, and strengthen our preparedness to fight future pathogens.

Combination therapy patents: a new front in evergreening

Nature Biotechnology
Volume 39 Issue 12, December 2021
https://www.nature.com/nbt/volumes/39/issues/12

 

Patents | 08 December 2021
Combination therapy patents: a new front in evergreening
As pharmaceutical companies seek patent protection for combinations of cancer therapeutics, it is worthwhile to assess what constitutes an ‘unexpected result’ for the purpose of an appropriate patent and whether randomized, controlled trials of drug combinations have the ability to generate them.
Garth W. Strohbehn, Alec J. Kacew, Mark J. Ratain

Understanding resistance to medical AI

Nature Human Behaviour
Volume 5 Issue 12, December 2021
https://www.nature.com/nathumbehav/volumes/5/issues/12

 

Understanding resistance to medical AI
Previous research has shown that patients are reluctant to use medical artificial intelligence (AI). Cadario et al. find that this reluctance is due to people perceiving algorithms as a ‘black box’, coupled with an illusory sense of understanding medical decisions made by humans. Brief interventions that target subjective understanding of medical AI increase people’s willingness to use it…

Aspiring to greater intellectual humility in science

Nature Human Behaviour
Volume 5 Issue 12, December 2021
https://www.nature.com/nathumbehav/volumes/5/issues/12

 

Perspective | 28 October 2021
Aspiring to greater intellectual humility in science
Although intellectual humility is a prerequisite for credible science, it is rarely practised. Hoekstra and Vazire make recommendations on how to increase intellectual humility in research articles and highlight the crucial role of peer reviewers in promoting intellectually humble manuscripts.
Rink Hoekstra, Simine Vazire

Prepare developed democracies for long-run economic slowdowns

Nature Human Behaviour
Volume 5 Issue 12, December 2021
https://www.nature.com/nathumbehav/volumes/5/issues/12

 

Perspective | 18 November 2021
Prepare developed democracies for long-run economic slowdowns
The coming years are likely to see slowing economic growth, which has significant consequences for developed democracies. This Perspective by Burgess et al. considers the implications of slowed growth and proposes a guided civic revival approach to addressing challenges.
Matthew G. Burgess, Amanda R. Carrico, Steve Vanderheiden

Understanding, explaining, and utilizing medical artificial intelligence

Nature Human Behaviour
Volume 5 Issue 12, December 2021
https://www.nature.com/nathumbehav/volumes/5/issues/12

 

Article | 28 June 2021
Understanding, explaining, and utilizing medical artificial intelligence
Cadario et al. identify potential reasons underlying the resistance to use medical artificial intelligence and test interventions to overcome this resistance.
Romain Cadario, Chiara Longoni, Carey K. Morewedge

No causal effect of school closures in Japan on the spread of COVID-19 in spring 2020

Nature Medicine
Volume 27 Issue 12, December 2021
https://www.nature.com/nm/volumes/27/issues/12

 

Article | 27 October 2021 | Open Access
No causal effect of school closures in Japan on the spread of COVID-19 in spring 2020
School closures in municipalities in Japan at the start of the COVID-19 pandemic showed no significant reduction in cases compared with case counts in municipalities with open schools, questioning the utility of school closures in mitigating community spread of severe acute respiratory syndrome coronavirus 2.
Kentaro Fukumoto, Charles T. McClean, Kuninori Nakagawa

The impact of school opening model on SARS-CoV-2 community incidence and mortality

Nature Medicine
Volume 27 Issue 12, December 2021
https://www.nature.com/nm/volumes/27/issues/12

 

Article | 27 October 2021
The impact of school opening model on SARS-CoV-2 community incidence and mortality
Results from a nationwide cohort study in the United States indicates that schools can reopen for in-person learning without substantially increasing community case rates of SARS-CoV-2.
Zeynep Ertem, Elissa M. Schechter-Perkins, Richard E. Nelson

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Nature Medicine
Volume 27 Issue 12, December 2021
https://www.nature.com/nm/volumes/27/issues/12

 

Article | 14 October 2021 | Open Access
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
A large, community-based study in the United Kingdom indicates that the effectiveness of BNT162b2 and ChAdOx1 vaccines against SARS-CoV-2 infections with symptoms or high viral burden is reduced with the Delta variant compared to the Alpha variant.
Koen B. Pouwels, Emma Pritchard, A. Sarah Walker

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar

Nature Medicine
Volume 27 Issue 12, December 2021
https://www.nature.com/nm/volumes/27/issues/12

 

Article | 02 November 2021
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
mRNA COVID-19 vaccines are highly effective at preventing severe outcomes and death caused by the SARS-CoV-2 Delta variant (B.1.617.2) in Qatar despite substantially lower effectiveness at blocking infection.
Patrick Tang, Mohammad R. Hasan, Laith J. Abu-Raddad

Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 18 Dec 2021)

 

Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study
Mie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Anne Katrine Bjørkholt Sørensen, Palle Valentiner-Branth, Hanne-Dorthe Emborg
Research Article | published 17 Dec 2021 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003874

Oncologists’ reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center

PLoS One
http://www.plosone.org/
[Accessed 18 Dec 2021]

 

Research Article
Oncologists’ reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center
Jeremiah Stout, Cambray Smith, Jan Buckner, Alex A. Adjei, Mark Wentworth, Jon C. Tilburt, Zubin Master
Research Article | published 17 Dec 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0261478

Factors of parental COVID-19 vaccine hesitancy: A cross sectional study in Japan

PLoS One
http://www.plosone.org/
[Accessed 18 Dec 2021]

 

Factors of parental COVID-19 vaccine hesitancy: A cross sectional study in Japan
Sayaka Horiuchi, Haruka Sakamoto, Sarah K. Abe, Ryoji Shinohara, Megumi Kushima, Sanae Otawa, Hideki Yui, Yuka Akiyama, Tadao Ooka, Reiji Kojima, Hiroshi Yokomichi, Kunio Miyake, Takashi Mizutani, Zentaro Yamagata
Research Article | published 17 Dec 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0261121

A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia

PLoS One
http://www.plosone.org/
[Accessed 18 Dec 2021]

 

A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia
Sukamto Koesnoe, Nuning Masjkuri, Asri Adisasmita, Samsuridjal Djauzi, Cissy Kartasasmita, Julitasari Sundoro, Mardiati Nadjib, Mondastri Korib, Alisa Nurul Muthia, Virly Nanda Muzellina, Ummu Habibah, Saskia Aziza Nursyirwan, Kristoforus Hendra Djaya, Novilia Sjafri Bachtiar, Rini Mulia Sari
Research Article | published 16 Dec 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0250234

Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics

PLoS One
http://www.plosone.org/
[Accessed 18 Dec 2021]

 

Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics
Torgyn Issa, Aisha Babi, Alpamys Issanov, Ainur Akilzhanova, Kadisha Nurgaliyeva, Zauresh Abugalieva, Azliyati Azizan, Saleem A. Khan, Chee Kai Chan, Raushan Alibekova, Gulzhanat Aimagambetova
Research Article | published 13 Dec 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0261203

Religious identity cues increase vaccination intentions and trust in medical experts among American Christians

PNAS – Proceedings of the National Academy of Sciences of the United States
December 07, 2021; vol. 118 no. 49
https://www.pnas.org/content/118/49

 

Brief Report
Open Access
Religious identity cues increase vaccination intentions and trust in medical experts among American Christians
James Chu, Sophia L. Pink, and Robb Willer
PNAS December 7, 2021 118 (49) e2106481118; https://doi.org/10.1073/pnas.2106481118

Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021

PNAS – Proceedings of the National Academy of Sciences of the United States
December 07, 2021; vol. 118 no. 49
https://www.pnas.org/content/118/49

 

Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021
Scott E. Bokemper, Alan S. Gerber, Saad B. Omer, and Gregory A. Huber
PNAS December 7, 2021 118 (49) e2114762118; https://doi.org/10.1073/pnas.2114762118

The role of trust in the likelihood of receiving a COVID-19 vaccine: Results from a national survey

Preventive Medicine
Volume 153 December 2021
https://www.sciencedirect.com/journal/preventive-medicine/vol/153/suppl/C

 

Research article Full text access
The role of trust in the likelihood of receiving a COVID-19 vaccine: Results from a national survey
Peter G. Szilagyi, Kyla Thomas, Megha D. Shah, Nathalie Vizueta, … Arie Kapteyn
Article 106727

Time and geographic variations in human papillomavirus vaccine uptake in Washington state

Preventive Medicine
Volume 153 December 2021
https://www.sciencedirect.com/journal/preventive-medicine/vol/153/suppl/C

 

Research article Full text access
Time and geographic variations in human papillomavirus vaccine uptake in Washington state
Nastaran Pourebrahim, Parth Shah, Trang VoPham, David R. Doody, … Margaret M. Madeleine
Article 106753

Looking ahead in the COVID-19 pandemic: emerging lessons learned for sexual and reproductive health services in low- and middle-income countries

Reproductive Health
http://www.reproductive-health-journal.com/content
[Accessed 18 Dec 2021]

 

Looking ahead in the COVID-19 pandemic: emerging lessons learned for sexual and reproductive health services in low- and middle-income countries
Authors: Aduragbemi Banke-Thomas and Sanni Yaya
Content type: Editorial
14 December 2021